These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 16896669)

  • 1. Uptake of 4-borono-2-[18F]fluoro-L-phenylalanine in sporadic and neurofibromatosis 2-related schwannoma and meningioma studied with PET.
    Havu-Aurén K; Kiiski J; Lehtiö K; Eskola O; Kulvik M; Vuorinen V; Oikonen V; Vähätalo J; Jääskeläinen J; Minn H
    Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):87-94. PubMed ID: 16896669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
    Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
    J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive estimation of
    Yoshimoto M; Honda N; Kurihara H; Hiroi K; Nakamura S; Ito M; Shikano N; Itami J; Fujii H
    Cancer Sci; 2018 May; 109(5):1617-1626. PubMed ID: 29498142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of 4-borono-2-18F-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model.
    Wang HE; Liao AH; Deng WP; Chang PF; Chen JC; Chen FD; Liu RS; Lee JS; Hwang JJ
    J Nucl Med; 2004 Feb; 45(2):302-8. PubMed ID: 14960653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-Borono-2-
    Ishiwata K
    Ann Nucl Med; 2019 Apr; 33(4):223-236. PubMed ID: 30820862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroPET-based pharmacokinetic analysis of the radiolabeled boron compound [18F]FBPA-F in rats with F98 glioma.
    Chen JC; Chang SM; Hsu FY; Wang HE; Liu RS
    Appl Radiat Isot; 2004 Nov; 61(5):887-91. PubMed ID: 15308163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the total distribution volume of
    Romanov V; Isohashi K; Alobthani G; Beshr R; Horitsugi G; Kanai Y; Naka S; Watabe T; Shimosegawa E; Hatazawa J
    Ann Nucl Med; 2020 Mar; 34(3):155-162. PubMed ID: 31808134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic analysis and uptake of 18F-FBPA-Fr after ultrasound-induced blood-brain barrier disruption for potential enhancement of boron delivery for neutron capture therapy.
    Yang FY; Chang WY; Li JJ; Wang HE; Chen JC; Chang CW
    J Nucl Med; 2014 Apr; 55(4):616-21. PubMed ID: 24525207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar T/N ratio between
    Lin YC; Chou FI; Yang BH; Chang CW; Chen YW; Hwang JJ
    Ann Nucl Med; 2020 Jan; 34(1):58-64. PubMed ID: 31650410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET pharmacokinetic analysis to estimate boron concentration in tumor and brain as a guide to plan BNCT for malignant cerebral glioma.
    Nariai T; Ishiwata K; Kimura Y; Inaji M; Momose T; Yamamoto T; Matsumura A; Ishii K; Ohno K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S348-50. PubMed ID: 19375930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A unique in vivo assessment of 4-[10B]borono-L-phenylalanine in tumour tissues for boron neutron capture therapy of malignant melanomas using positron emission tomography and 4-borono-2-[18F]fluoro-L-phenylalanine.
    Ishiwata K; Shiono M; Kubota K; Yoshino K; Hatazawa J; Ido T; Honda C; Ichihashi M; Mishima Y
    Melanoma Res; 1992 Sep; 2(3):171-9. PubMed ID: 1450671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography and [18F]BPA: a perspective application to assess tumour extraction of boron in BNCT.
    Menichetti L; Cionini L; Sauerwein WA; Altieri S; Solin O; Minn H; Salvadori PA
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S351-4. PubMed ID: 19410471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodistribution of boron after intravenous 4-dihydroxyborylphenylalanine-fructose (BPA-F) infusion in meningioma and schwannoma patients: A feasibility study for boron neutron capture therapy.
    Kulvik M; Kallio M; Laakso J; Vähätalo J; Hermans R; Järviluoma E; Paetau A; Rasilainen M; Ruokonen I; Seppälä M; Jääskeläinen J
    Appl Radiat Isot; 2015 Dec; 106():207-12. PubMed ID: 26298436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predominant contribution of L-type amino acid transporter to 4-borono-2-(18)F-fluoro-phenylalanine uptake in human glioblastoma cells.
    Yoshimoto M; Kurihara H; Honda N; Kawai K; Ohe K; Fujii H; Itami J; Arai Y
    Nucl Med Biol; 2013 Jul; 40(5):625-9. PubMed ID: 23557719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary feasibility study on differential diagnosis between radiation-induced cerebral necrosis and recurrent brain tumor by means of [
    Beshr R; Isohashi K; Watabe T; Naka S; Horitsugi G; Romanov V; Kato H; Miyatake SI; Shimosegawa E; Hatazawa J
    Ann Nucl Med; 2018 Dec; 32(10):702-708. PubMed ID: 30194665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical calculation method to estimate the absolute boron concentration in tissues using
    Watabe T; Hanaoka K; Naka S; Kanai Y; Ikeda H; Aoki M; Shimosegawa E; Kirihata M; Hatazawa J
    Ann Nucl Med; 2017 Jul; 31(6):481-485. PubMed ID: 28439784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the applicability of [
    Grunewald C; Sauberer M; Filip T; Wanek T; Stanek J; Mairinger S; Rollet S; Kudejova P; Langer O; Schütz C; Blaickner M; Kuntner C
    Nucl Med Biol; 2017 Jan; 44():83-89. PubMed ID: 27837726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and therapeutic indicator of fluoroboronophenylalanine positron emission tomography in patients with gliomas.
    Takahashi Y; Imahori Y; Mineura K
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5888-95. PubMed ID: 14676111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of
    Shimosegawa E; Isohashi K; Naka S; Horitsugi G; Hatazawa J
    Ann Nucl Med; 2016 Dec; 30(10):749-755. PubMed ID: 27586407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
    Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ
    Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.